Karvela et al. demonstrated that loss of ATG7 resulted in metabolic reprogramming of CML cells, with impaired glycolysis and a shift towards OXPHOS, leading to ROS accumulation that caused CML CD34+ cells to differentiate towards the erythroid lineage [77]. Here, ATG7 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.